7 New Drugs for Neurologists

Here’s a brief look at therapies for neurological disorders that the FDA has approved within the past 6 months.

slideshow image

Here’s a brief overview of medications for neurological disorders that were approved or granted a new indication or an additional formulation by the FDA in the past 6 months.

Scroll through the slides for details about new treatments for multiple sclerosis, narcolepsy, migraine, Parkinson disease, pain, and Lennox-Gastaut syndrome.

Related Videos
Related Content
© 2023 MJH Life Sciences

All rights reserved.